wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Chapter 62: Dermatomyositis

Total questions: 41

Worksheet time: 41mins

Name
Class
Date
1.

All of the following are true about clinically amyopathic dermatomyositis, EXCEPT:

a)

Approximately 20% of dermatomyositis patients

b)

DM rash for 6 months without weakness by history or PE

c)

Normal strength but abnormal muscle enzymes

d)

Normal strength and normal muscle enzymes

e)

None of the above

2.

Which of the following are considered as major criteria for cutaneous dermatomyositis (select all possible answers):

a)

Heliotrope rash

b)

Gottron sign

c)

Shawl sign

d)

Gottron papules

e)

Holster sign

3.

All of the following are true about scalp involvement in dermatomyositis, EXCEPT:

a)

Pruritus is often mild or non-existent

b)

One of the most commonly involved sites

c)

Presents as a linear band just above and below the frontal hairline

d)

Not specific for dermatomyositis

4.

Identify the sign.


This pink to violet eruption can involve other areas, including which of the following (select all possible answers):

a)

Cheeks

b)

Neck

c)

Scalp

d)

Forehead

e)

Nose

5.

Identify the sign.

(a)  

6.

Identify the sign: confluent violaceous erythema on the sun-exposed areas of the lower anterior neck and anterior chest.

(a)  

7.

Identify the sign: violaceous to pink papules over the IP and MCP joints.

(a)  

8.

Identify the sign.


This symmetric macular violaceous erythema can be seen over the following areas (select all possible areas):

a)

MCP joints

b)

IP joints

c)

Patellae

d)

Olecranon process

e)

Lateral malleoli

9.

Identify the sign: violaceous erythema and poikiloderma on the lateral hips and lateral thighs.

(a)  

10.

Identify the sign: hyperkeratosis and fissuring along the medial thumb and lateral second and third digits.


QUESTION:

Dermatomyositis patients with this sign show increased prevalence of what systemic disease (spell out).

(a)  

11.

Which vasculopathic manifestation is highly suggestive of dematomyositis over other connective tissue disorders?

a)

Gingival telangiectasia

b)

Livedo reticularis

c)

Ulceration

d)

Proximal nailfold erythema

12.

All of the following are true regarding ulceration in dermatomyositis, EXCEPT:

a)

Associated with positive anti-MDA5 antibodies

b)

Necrotic ulcerations raises the concern for malignancy

c)

Worsening ulceration may be a sign of worsening ILD

d)

Often affects the flexor surfaces of the extremities

13.

This sign is associated with positive anti-transcriptional intermediary factor 1γ (TIF1-γ) antibodies.


Identify the sign.

(a)  

14.

Cutaneous disease activity in dermatomyositis is characterized by which of the following signs (select all possible answers):

a)

Erythema

b)

Itch

c)

Induration

d)

Scale

e)

Ulceration

15.

Identify this sign: reticulated white macules surrounded by telangiectatic red macules.


All of the following are true about this skin finding in dermatomyositis, EXCEPT:

a)

It is a sign of substantial inflammation

b)

It is also seen in other connective tissue diseases like lupus

c)

It is frequently seen over the bitemporal hairline

d)

It doesn't necessarily follow patterns of sun exposure

16.

Poikiloderma is a sign of significant damage after long-standing disease activity. It is characterized by which of the following (select all possible answers):

a)

Atrophy

b)

Hypopigmentation

c)

Hyperpigmentation

d)

Telangiectasias

17.

All of the following are true about calcinosis in dermatomyositis, EXCEPT:

a)

It is more prevalent in juvenile DM

b)

It most frequently presents as digital calcinosis

c)

Positive anti-nuclear matrix protein 2 (NXP-2) antibodies are associated with increased risk

d)

Vascular insufficiency or damage is involved in its pathogenesis

18.

All of the following are risk factors for development of calcinosis in juvenile DM, EXCEPT:

a)

Longer disease duration

b)

Younger age of onset

c)

Sustained disease activity

d)

Absence of internal organ involvement

19.

Anti-MDA5 antibodies are associated with all the following clinical findings in dermatomyositis, EXCEPT:

a)

Ulceration

b)

Violaceous patch over the hard palate

c)

Reticular pattern of erythema on the palms

d)

Calcinosis

e)

Severe alopecia

20.

All of the following are true about interstitial lung disease in dermatomyositis, EXCEPT:

a)

Leading cause of morbidity and mortality

b)

Most common pulmonary manifestation

c)

DM with anti-MDA5 antibodies have increased risk of developing ILD

d)

Most common radiographic pattern is cryptogenic organizing pneumonia

21.

Which diagnostic tool is necessary for establishing the diagnosis of interstitial lung disease in dermatomyositis?

a)

6-minute walk test

b)

Pulmonary function tests

c)

Chest x-ray

d)

High-resolution CT scan of the chest

22.

Which radiographic pattern of interstitial lung disease is associated with poor prognosis?

a)

Basilar and peripheral ground-glass opacities

b)

Subpleural sparing

c)

Cryptogenic organizing pneumonia

d)

Diffuse alveolar damage

23.

What is the gold standard for diagnosis of pulmonary arterial hypertension in dermatomyositis?

a)

Pulmonary function tests

b)

Transthoracic echocardiography

c)

High-resolution CT scan

d)

Right heart catheterization

24.

All of the following are true about muscle involvement in dermatomyositis, EXCEPT:

a)

Typical presentation is symmetrical proximal weakness

b)

About 80% of patients develop weakness within the first year of symptom onset

c)

Myalgia is always accompanied by weakness and is seen in 50% of patients

d)

Distal muscle weakness is associated with anti-NXP2 antibodies

25.

All of the following are true about gastrointestinal involvement in dermatomyositis, EXCEPT:

a)

Uncommon manifestation of adult DM

b)

Associated with more severe disease

c)

Life threatening sequelae include ulceration and perforation

d)

Results from vasculopathy affecting the bowel wall

26.

Subclinical cardiac muscle involvement can be detected using this useful biomarker:

(a)  

27.

Which of the following factors is associated with an INCREASED RISK for malignancy in dermatomyositis?

a)

Increasing age

b)

Male gender

c)

Cutaneous necrosis

d)

ILD

e)

Arthritis

28.

Which of the following factors is considered PROTECTIVE for malignancy in dermatomyositis?

a)

Dysphagia

b)

Rapid onset of myositis

c)

Raynaud phenomenon

d)

Arthritis

29.

Which of the following genes are associated with the development of dermatomyositis (select all the possible answers):

a)

HLA-B8

b)

BLK gene

c)

TYK2 gene

d)

HLA-B27

30.

All of the following are true about the pathogenesis of dermatomyositis, EXCEPT:

a)

Immune-mediated disorder of both innate and adaptive immunity

b)

Interface dermatitis with keratinocyte injury in the skin

c)

Atrophy, degeneration, and regeneration of muscle fibers

d)

Decreased levels of interferon (IFN)-induced genes and proteins

31.

Weakness symptoms of DM can be attributed to the following pathogenic factors, EXCEPT:

a)

Endoplasmic reticulum stress response

b)

Activation of NF-kB signaling pathways

c)

Decreased reactive oxygen species

d)

Mitochondrial dysfunction

32.

What physical signs are sensitive for dermatomyositis (select all possible answers):

a)

Lateral digit hyperkeratosis

b)

Scalp erythema and dyesthesia

c)

Microscopic periungual telangiectasia

d)

Ovoid palatal patch

e)

Gottron papules

33.

What physical signs are specific for dermatomyositis (select all possible answers):

a)

"Red-on-white" patches

b)

Ovoid palatal patch

c)

Grossly visible periungal telangiectasias

d)

Gottron papules

e)

Microscopic periungal telangiectasias

34.

Which serum muscle enzymes can be used to evaluate for myositis early on in the course of dermatomyositis (select all possible answers):

a)

Creatine kinase

b)

AST

c)

ALT

d)

Aldolase

e)

Lactate dehydrogenase

35.

Serum muscle enzymes can be falsely elevated in the following situations (select all possible answers):

a)

10-14 days after strenuous activity

b)

Liver disease

c)

Hemolysis of blood sample

d)

Kidney disease

36.

What alternative biomarker can be used for DM patients with anti-MDA5 antibodies that reflects the clinical response of ILD?

(a)  

37.

All of the following are true about the histopathologic findings of dermatomyositis in the skin, EXCEPT:

a)

Interface dermatitis

b)

Dense infiltrates

c)

Increased dermal mucin

d)

Epidermal atrophy

e)

Basement membrane thickening

38.

All of the following are true about histopathology of the muscle (muscle biopsy) in dermatomyositis, EXCEPT:

a)

Required to establish the diagnosis of DM

b)

Highest yield if performed within 2 weeks of beginning any immunomodulatory therapy

c)

Histopathology shows perifascular atrophy and degenerating and regenerating myofibers

d)

False-negative results can be due to patchy inflammation

39.

Which of the following are considered the major causes of death in dermatomyositis (select all possible answers):

a)

Malignancy

b)

Pulmonary disease

c)

Cardiac disease

d)

Infection

40.

Which autoantibody is considered a risk factor for mortality?

a)

anti-MDA5

b)

anti-TIFI-y

c)

anti-NXP-2

d)

antisynthetase

41.

All of the following are true about cancer screening in dermatomyositis, EXCEPT:

a)

30% of DM patients have an associated malignancy

b)

Routine age-appropriate screening is recommended on initial diagnosis

c)

More aggressive screening may detect occult malignancies within the higher risk period (2-3 years from diagnosis)

d)

Blind rescreening should be considered with difficult to control or flare of disease